menu search

DYAI / Dyadic reports 21.9% revenue rise, $12.7M in cash for full year 2022 as it rapidly advances technology

Dyadic reports 21.9% revenue rise, $12.7M in cash for full year 2022 as it rapidly advances technology
Dyadic International Inc (NASDAQ:DYAI) posted its financial results for the year ended 2022 with revenue surging 21.9% year-over-year on the back of license agreements as it rapidly advanced its technology. For the year ended December 31, 2022, the Jupiter, Florida-based biotechnology platform company reported research and development (R&D) revenue of $2.93 million, compared to $2.40 million for the year ended December 31, 2021. Read More
Posted: Mar 30 2023, 09:51
Author Name: Proactive Investors
Views: 122468

DYAI News  

Dyadic to Present at Industry and Investor Events in October

By GlobeNewsWire
September 29, 2023

Dyadic to Present at Industry and Investor Events in October

JUPITER, Fla., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnolo more_horizontal

Dyadic to Present at BioProcess International

By GlobeNewsWire
September 12, 2023

Dyadic to Present at BioProcess International

JUPITER, Fla., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnolo more_horizontal

Dyadic International, Inc. (DYAI) Q2 2023 Earnings Call Transcript

By Seeking Alpha
August 9, 2023

Dyadic International, Inc. (DYAI) Q2 2023 Earnings Call Transcript

Dyadic International, Inc. (NASDAQ:DYAI ) Q2 2023 Earnings Conference Call August 9, 2023 5:00 PM ET Company Participants Ping Rawson - Chief Financia more_horizontal

Dyadic to Report Second Quarter 2023 Financial Results on Wednesday, August 9, 2023

By GlobeNewsWire
July 26, 2023

Dyadic to Report Second Quarter 2023 Financial Results on Wednesday, August 9, 2023

JUPITER, Fla., July 26, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDA more_horizontal

Dyadic International, Inc. (DYAI) Q1 2023 Earnings Call Transcript

By Seeking Alpha
May 10, 2023

Dyadic International, Inc. (DYAI) Q1 2023 Earnings Call Transcript

Dyadic International, Inc. (NASDAQ:DYAI ) Q1 2023 Earnings Conference Call May 10, 2023 5:00 PM ET Company Participants Ping Rawson - Chief Financial more_horizontal

Dyadic reports 21.9% revenue rise, $12.7M in cash for full year 2022 as it rapidly advances technology

By Proactive Investors
March 30, 2023

Dyadic reports 21.9% revenue rise, $12.7M in cash for full year 2022 as it rapidly advances technology

Dyadic International Inc (NASDAQ:DYAI) posted its financial results for the year ended 2022 with revenue surging 21.9% year-over-year on the back of more_horizontal

Dyadic to Present at World Vaccine Congress Washington 2023

By GlobeNewsWire
March 30, 2023

Dyadic to Present at World Vaccine Congress Washington 2023

JUPITER, Fla., March 30, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnolo more_horizontal

Dyadic International, Inc. (DYAI) Q4 2022 Earnings Call Transcript

By Seeking Alpha
March 29, 2023

Dyadic International, Inc. (DYAI) Q4 2022 Earnings Call Transcript

Dyadic International, Inc. (NASDAQ:DYAI ) Q4 2022 Results Conference Call March 29, 2023 5:00 PM ET Company Participants Ping Rawson - Chief Financial more_horizontal


Search within

Pages Search Results: